This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Mar-Apr;146(3):183-96.

doi: 10.1016/0923-2494(96)80256-2.

CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?

S W van Gool¹, S Barcy, S Devos, P Vandenberghe, J L Ceuppens, K Thielemans, M de Boer

Affiliations

PMID: 8525052
DOI: 10.1016/0923-2494(96)80256-2

Review

CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?

S W van Gool et al. Res Immunol. 1995 Mar-Apr.

. 1995 Mar-Apr;146(3):183-96.

doi: 10.1016/0923-2494(96)80256-2.

Authors

S W van Gool¹, S Barcy, S Devos, P Vandenberghe, J L Ceuppens, K Thielemans, M de Boer

Affiliation

¹ Department of Pathophysiology, Catholic University of Leuven, Belgium.

PMID: 8525052
DOI: 10.1016/0923-2494(96)80256-2

No abstract available

PubMed Disclaimer

Similar articles

The complexities of T-cell co-stimulation: CD28 and beyond.
Sperling AI, Bluestone JA. Sperling AI, et al. Immunol Rev. 1996 Oct;153:155-82. doi: 10.1111/j.1600-065x.1996.tb00924.x. Immunol Rev. 1996. PMID: 9010723 Review. No abstract available.
Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
Minguela A, Sánchez-Bueno F, Marín L, Miras M, Pons JA, Muro M, Torío A, García-Alonso AM, Robles R, Parrilla P, Ramirez P, Alvarez-López MR. Minguela A, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1384-5. doi: 10.1016/s0041-1345(00)02520-3. Transplant Proc. 2001. PMID: 11267338 No abstract available.
Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL. Van Gool SW, et al. Eur J Immunol. 1999 Aug;29(8):2367-75. doi: 10.1002/(SICI)1521-4141(199908)29:08<2367::AID-IMMU2367>3.0.CO;2-3. Eur J Immunol. 1999. PMID: 10458748
Treatment of autoimmunity by inhibition of T cell costimulation.
Daikh DI, Wofsy D. Daikh DI, et al. Adv Exp Med Biol. 2001;490:113-7. doi: 10.1007/978-1-4615-1243-1_12. Adv Exp Med Biol. 2001. PMID: 11505969 Review. No abstract available.
Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P. Lane P. Ann N Y Acad Sci. 1997 Apr 5;815:392-400. doi: 10.1111/j.1749-6632.1997.tb52090.x. Ann N Y Acad Sci. 1997. PMID: 9186685 Review.

See all similar articles

Cited by

Integrated analysis reveals the potential of cluster of differentiation 86 as a key biomarker in high-grade glioma.
Wen X, Wang C, Pan Z, Jin Y, Wang H, Zhou J, Sun C, Ye G, Chen M. Wen X, et al. Aging (Albany NY). 2023 Dec 26;15(24):15402-15418. doi: 10.18632/aging.205359. Epub 2023 Dec 26. Aging (Albany NY). 2023. PMID: 38154107 Free PMC article.
The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment.
Hassanian H, Asadzadeh Z, Baghbanzadeh A, Derakhshani A, Dufour A, Rostami Khosroshahi N, Najafi S, Brunetti O, Silvestris N, Baradaran B. Hassanian H, et al. Front Immunol. 2022 Jul 28;13:938063. doi: 10.3389/fimmu.2022.938063. eCollection 2022. Front Immunol. 2022. PMID: 35967381 Free PMC article. Review.
Integrating machine learning algorithms and multiple immunohistochemistry validation to unveil novel diagnostic markers based on costimulatory molecules for predicting immune microenvironment status in triple-negative breast cancer.
Zhang C, Zhai W, Ma Y, Wu M, Cai Q, Huang J, Zhou Z, Duan F. Zhang C, et al. Front Immunol. 2024 Jun 28;15:1424259. doi: 10.3389/fimmu.2024.1424259. eCollection 2024. Front Immunol. 2024. PMID: 39007147 Free PMC article.
Mesenchymal stem cells activate Notch signaling to induce regulatory dendritic cells in LPS-induced acute lung injury.
Lu Z, Meng S, Chang W, Fan S, Xie J, Guo F, Yang Y, Qiu H, Liu L. Lu Z, et al. J Transl Med. 2020 Jun 16;18(1):241. doi: 10.1186/s12967-020-02410-z. J Transl Med. 2020. PMID: 32546185 Free PMC article.
Lentiviral delivery of CTLA-4 shRNA improves the expansion of cytokine-induced killer cells and enhances cytotoxic activity in vitro.
Rui T, Cheng X, Wu H, Wang F, Ye Z, Wu G. Rui T, et al. Oncol Lett. 2018 Jan;15(1):741-746. doi: 10.3892/ol.2017.7376. Epub 2017 Nov 9. Oncol Lett. 2018. PMID: 29399145 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database